Literature DB >> 2157613

Pigmented lesions of the retinal pigment epithelium and familial adenomatous polyposis.

P J Polkinghorne1, S Ritchie, K Neale, G Schoeppner, J P Thomson, B S Jay.   

Abstract

Bilateral pigmented fundus lesions were found in 65 out of 72 patients with familial adenomatous polyposis, an additional five patients having unilateral lesions. With a family history of familial adenomatous polyposis, the occurrence of multiple bilateral fundus lesions indicates the presence of the abnormal gene, as does the occurrence of oval pigmented lesions with surrounding pale haloes. The absence of pigmented fundus lesions does not exclude the abnormal genotype, while the presence of occasional pigmented spots can be found in an appreciable percentage of the population. Ocular examination would, however, appear to be valuable in screening those at risk, with a positive yield in most carriers of the gene for familial adenomatous polyposis.

Entities:  

Mesh:

Year:  1990        PMID: 2157613     DOI: 10.1038/eye.1990.29

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  11 in total

1.  Congenital hypertrophy of the retinal pigment epithelium (CHRPE) in familial colorectal cancer.

Authors:  Celia S Chen; Kerry D Phillips; Scott Grist; Graeme Bennet; Jamie E Craig; James S Muecke; Graeme K Suthers
Journal:  Fam Cancer       Date:  2006-08-31       Impact factor: 2.375

2.  Flecked chorioretinopathy associated with Birt-Hogg-Dubé syndrome.

Authors:  P Walter; B Kirchhof; B Korge; K Heimann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

3.  The role of congenital hypertrophy of the retinal pigment epithelium in screening for familial adenomatous polyposis.

Authors:  W J Campbell; R A Spence; T G Parks
Journal:  Int J Colorectal Dis       Date:  1994       Impact factor: 2.571

4.  Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis.

Authors:  S V Hodgson; D T Bishop; B Jay
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

5.  Diagnostic value of fundus examination in familial adenomatous polyposis.

Authors:  A Tiret; M Taiel-Sartral; E Tiret; L Laroche
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

6.  Attitudes to predictive DNA testing in familial adenomatous polyposis.

Authors:  S Whitelaw; J M Northover; S V Hodgson
Journal:  J Med Genet       Date:  1996-07       Impact factor: 6.318

7.  Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.

Authors:  Rosario Touriño; Rogelio Conde-Freire; José M Cabezas-Agrícola; Teresa Rodríguez-Aves; Maria Jesús López-Valladares; José L Otero-Cepeda; Carmen Capeans
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

8.  The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.

Authors:  J Burn; P Chapman; J Delhanty; C Wood; F Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

9.  Genotype-phenotype correlation between position of constitutional APC gene mutation and CHRPE expression in familial adenomatous polyposis.

Authors:  Y L Wallis; F Macdonald; M Hultén; J E Morton; C M McKeown; J P Neoptolemos; M Keighley; D G Morton
Journal:  Hum Genet       Date:  1994-11       Impact factor: 4.132

10.  Familial adenomatous polyposis.

Authors:  N C Armitage
Journal:  J R Soc Med       Date:  1992-02       Impact factor: 18.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.